Harsch Mutya 4
4 · VYNE Therapeutics Inc. · Filed Dec 15, 2023
Insider Transaction Report
Form 4
Harsch Mutya
CHIEF LEGAL OFFICER AND GC
Transactions
- Award
Common Stock
2023-12-13+62,500→ 87,096 total - Award
Stock Option (right to buy)
2023-12-13+62,500→ 62,500 totalExercise: $2.70Exp: 2033-12-12→ Common Stock (62,500 underlying)
Footnotes (3)
- [F1]Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.
- [F3]The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.